Intrahepatic CD69⁺Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression

Abstract

The enrichment of tissue-resident CD69⁺ Vδ1 T_EMRA cells re-circulating at high frequencies in PB of patients with CLM limits tumor progression and represents a new important clinical tool to either predict the natural history of CLM or develop alternative therapeutic protocols of cellular therapies.